We help international healthcare companies, investors, and innovation hubs navigate US expansion with confidence.

We’re different– because we’ve been dedicated to supporting innovators and their investors scale globally for the last decade.

We’re a small team with deep international experience, having lived professionally across Europe and South America for a decade prior to launching Venture Atlas Labs. 

Our early careers took us through innovation development in academia, sales and marketing leadership within both Fortune 100 companies and startups, executive roles at publicly-traded companies, non-dilutive funding efforts from federal institutions, and high-growth positions in growth and acquisition capital. 

The following ten years growing Venture Atlas Labs taught us how to refine the nuances between investment and innovation as companies scale internationally. 

We witnessed supporting organizations commit to a template of innovation theater that didn’t particularly help international healthtech companies navigate the US and certainly didn’t leverage their strengths. Wearing our investment hats and leveraging our experience from all sides of innovation, we found this inefficiency frustrating and unnecessary—so we set out to change that. 

Who we work with

We’re immensely proud of our relationships with healthcare systems across the US, which help inform the insights, advice, and knowledge we share with our clients.

  • Everything you need to enter the US, speed up time-to-market, and navigate this complex market efficiently.

    • US commercial planning

    • Market access information

    • Strategic partners

    You can get direct insights with easy consulting credits or get us to create or validate your roadmap via a custom project.

    Or, if you’re just looking at the US market, we recommend applying for the Healthtech Bridge program.

  • From commercial support to FDI, we drive measurable progress across borders.

    • Portfolio consulting and support

    • Trade missions

    • Business development

    • Investment events

  • We uplift new ideas and leaders with real-world frameworks, action-driven workshops, and investment planning.

    • Commercialization insights

    • Non-dilutive and dilutive planning

    • Business training

  • We partner with new business units focused on market expansion to develop critical competitive edges

    • Innovation and acquisition scouting

    • Sales research

    • US sales workshops

  • VC, PE, CVC, and family offices all benefit from niche expertise, deep industry insights, and proprietary frameworks

    • Contextualized due diligence

    • Commercial risk mitigation

    • Deal sourcing

  • If you have your eye on FDA approval, it’s time to get serious about commercialization and market access planning.

    • Sales strategy

    • Market positioning

    • Clinical and workflow cases

    • Revenue impact case

    • Strategic partnerships

  • Assisting corporations and PE, we bring relevant insight to make decisions faster and with stronger context.

    • Deal scouting

    • Commercial research

    • Intangible valuations

    • Strategic fit evaluations

  • Expert opinions, assessments, and ad-hoc advice for cases or white-label consulting across healthcare.

    • Commercial due diligence

    • Buy-side due diligence

    • Scenario expertise

The team

Depending on the project, we leverage our extensive Rolodex of trusted advisors from across healthcare and investment.

Elizabeth Jennings

Elizabeth has worked at the intersection of international investment and commercialization within healthcare for the last 15 years, spanning 28 countries and all classes of complexity, building a reputation for strategic risk management for both investors and companies.

She is on the Board of Directors of a business angel network, SWAN Impact, where she focuses on impact-driven healthcare startup investments. Leveraging experience working with large public companies through startups while living in Europe and South America, she is the healthtech lead at the European Network of Research Innovation Centres and Hubs (ENRICH), where she supports European entrepreneurs' soft landing into 18 hubs across the US.

She has worked in global innovation in academia at the leading university in Texas, and she serves as a US federal grant reviewer for medical devices, an advisor to numerous accelerators, and is a frequent keynote speaker. 

She is an advisor to a number of AI and medical device startups and an active supporter of neglected tropical disease initiatives.

Focus areas:

  • Cardiology, oncology, and neurology

  • AI

  • Health economics

  • In-vitro diagnostics

  • Robotics

Christina Brinch Clark

As an experienced management consultant and trusted life science advisor, Christina provides high‐value direction on international business development, market-entry, and brand-building programs focused on strategic partnership development.

Residing in NYC, Christina spent 20 years in Houston, Texas, where she managed global brand initiatives for industry leaders in energy (ExxonMobil), technology (HPE), healthcare (MD Anderson Cancer Center), and life science (Ministry of Foreign Affairs of Denmark).

Christina specializes in healthcare and life science and built a network and experience with hospital leaders and the life science industry across the US and the Nordics. As advisor to the Ministry of Foreign Affairs of Denmark, she co-founded and chaired the Texas Medical Center | Denmark BioBridge – an international MoU signed by TMC and the Kingdom of Denmark.

She holds a Master’s in International Business Communication from Copenhagen Business School and studied Corporate Innovation at Rice University – Jones Graduate School of Business.

Focus areas:

  • Women’s health

  • Brain health

  • Gut microbiome

  • Sustainable healthcare

  • Value-based and accountable care innovation

Our values

  • We’re never going to drop a stack of superfluous reports in your inbox that don’t inform decisions. Instead, we just give you the best, straightforward information possible. 

  • We’re as exhausted by fly-by-night consultants as you are, because we’ve been on your side of the table. Instead, we aim to be actually useful because we want you to succeed. 

  • We stay in the deep end, not in the side lines. We don’t just give out armchair advice. We put to practice what we preach. 

  • We don’t play games with our partners (that’s you!) because we treat our partners like, well, partners. If we know the answer or can point you in the right direction right then and there, we will. See how consulting works. 

  • We’re geographically agnostic. While we’re headquartered in Paris, France, we work across the US. Our network of healthcare providers and partners is diversified across the US, as well as our network of soft landing options. 

  • We take confidentiality very seriously. We’re often privy to privileged information which sometimes prohibits us from taking on competitors. We proactively recuse ourselves from these conflicting situations. 

  • We’re not in this to be extractive. We know the investment world, from early-stage investing through private equity, and we know what both working on a runway is like–and what it means to be responsible stewards of LPs’ capital. We strive to provide top tier services that provide truly impactful value. 

  • We show up for diplomacy. We believe the best path forward to building a more peaceful planet is through international collaboration with companies that improve the health and well being of citizens everywhere. 

Head of Innovation | Neurology | Class II Device | Scaleup

“Thank you for saving me! Without your consideration and advice, I would have been a train wreck. Your insights and humor have made all the difference.”

Chief Marketing Officer | Oncology | AI | Scaleup

“I’m still spinning that your team was able to unstick our problems. None of this is obvious, but we couldn’t have seen what we needed to do without you.”

Portfolio Manager | PE fund | Medical devices

“We wouldn’t trust many firms with this level of input into the direction of our companies, but we were impressed from the beginning with the level of experience your team had. We’ve appreciated your reliability over the years and have full confidence in your insights.”

Director of Healthcare | Ministry of Foreign Affairs | Commercialization workshops

“We didn’t expect the workshop to be so well-received or, honestly, to get so much from it. This is something that needs to be in the budget every year.”

Contact us

Venture Atlas labs

© 2024 | All rights reserved | Privacy Policy